OBJECTIVE
To perform a meta-analysis of case-control studies that addressed whether prior oral
contraceptive (OC) use is associated with premenopausal breast cancer.
METHODS
We searched the MEDLINE and PubMed databases and bibliography reviews to identify
case-control studies of OCs and premenopausal breast cancer published in or after
1980. Search terms used included breast neoplasms, oral contraceptives, contraceptive agents, and case-control studies. Studies reported in all languages were included. Thirty-four studies were identified
that met inclusion criteria. Two reviewers extracted data from original research articles
or additional data provided by study authors. We used the DerSimonian-Laird method
to compute pooled odds ratios (ORs) and confidence intervals (CIs) and the Mantel-Haenszel
test to assess association between OC use and cancer.
RESULTS
Use of OCs was associated with an increased risk of premenopausal breast cancer in
general (OR, 1.19; 95% CI, 1.09-1.29) and across various patterns of OC use. Among
studies that provided data on nulliparous and parous women separately, OC use was
associated with breast cancer risk in both parous (OR, 1.29; 95% CI, 1.20-1.40) and
nulliparous (OR, 1.24; 95% CI, 0.92-1.67) women. Longer duration of use did not substantially
alter risk in nulliparous women (OR, 1.29; 95% CI, 0.85-1.96). Among parous women,
the association was stronger when OCs were used before first full-term pregnancy (FFTP)
(OR, 1.44; 95% CI, 1.28-1.62) than after FFTP (OR, 1.15; 95% CI, 1.06-1.26). The association
between OC use and breast cancer risk was greatest for parous women who used OCs 4
or more years before FFTP (OR, 1.52; 95% CI, 1.26-1.82).
CONCLUSION
Use of OCs is associated with an increased risk of premenopausal breast cancer, especially
with use before FFTP in parous women.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Mayo Clinic ProceedingsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
REFERENCES
- Cancer statistics, 2005 [published correction appears in CA Cancer J Clin. 2005;55:259].CA Cancer J Clin. 2005; 55: 10-30
- Breast cancer facts and figures 2003-2004. Atlanta (GA): American Cancer Society; c2003.(Accessed September 5, 2006.)
- Ries LAG Eisner MP Kosary CL SEER Cancer Statistics Review, 1973-1999. National Cancer Institute, Bethesda (MD)2002 (Accessed September 5, 2006.)
- Lactation and a reduced risk of premenopausal breast cancer.N Engl J Med. 1994; 330: 81-87
- Evidence for a protective effect of lactation on risk of breast cancer in young women: results from a case-control study.Am J Epidemiol. 1986; 124: 353-358
- Breast cancer and reproductive history of women in South Wales.Lancet. 1970; 1: 153-156
- Breast cancer in an area of high parity: Sao Paulo, Brazil.Cancer Res. 1971; 31: 77-83
- Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.JAMA. 2003; 289: 3243-3253
- IARC monographs programme finds combined estrogen-progestogen contraceptives and menopausal therapy are carcinogenic to humans [press release 167].Available at: www.iarc.fr/ENG/Press_Releases/pr167a.html(Accessed September 1, 2006.)Date: July 29, 2005
- Oral contraceptives and breast cancer: review and meta-analysis.Cancer. 1990; 66: 2253-2263
- Breast cancer and hormonal contraceptives: further results.Contraception. 1996; 54: 1S-106S
- Oral contraceptives and breast cancer: review of the epidemiologic literature.Contraception. 1991; 43: 597-642
- Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports.J Am Board Fam Pract. 1993; 6: 123-135
- Oral contraceptives and breast cancer: a meta-analysis.Rev Epidemiol Sante Publique. 1991; 39: 165-181
- Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use.Br J Obstet Gynaecol. 1992; 99: 239-246
- Cancer risk related to mammary gland structure and development.Microsc Res Tech. 2001; 52: 204-223
- A review of the epidemiology of human breast cancer.Epidemiol Rev. 1979; 1: 74-109
- Risk factors for breast cancer.Am J Epidemiol. 1983; 117: 35-45
- A case-control study of menopausal estrogen therapy and breast cancer.JAMA. 1980; 243: 1635-1639
- Oral contraceptives and breast cancer: results from an expanded case-control study.Br J Cancer. 1989; 60: 375-381
- Oral contraceptives and premenopausal bilateral breast cancer: a case-control study.Epidemiology. 1992; 3: 414-419
- Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.Lancet. 1983; 2: 926-930
- Consistent lack of association between breast cancer and oral contraceptives using either hospital or neighborhood controls.Prev Med. 1993; 22: 178-186
- Oral contraceptives and breast cancer: final report of an epidemiological study.Br J Cancer. 1983; 47: 455-462
- Oral contraceptives and breast cancer: a case-control study with hospital and community controls.Obstet Gynecol. 1990; 76: 395-402
- Noncontraceptive hormone use and risk of breast cancer.Cancer Causes Control. 1992; 3: 475-479
- Oral contraceptive use and risk of breast cancer in middle-aged women.Am J Epidemiol. 1996; 144: 161-164
- Oral contraceptives and breast cancer in northern Italy: final report from a case-control study.Br J Cancer. 1993; 68: 568-571
- Oral contraceptives and breast cancer: a cooperative Italian study.Int J Cancer. 1995; 60: 163-167
- Risk factors for breast cancer in women under 40 years.Eur J Cancer. 1999; 35: 1361-1367
- Abortion history and breast cancer risk: results from the Shanghai Breast Cancer Study.Int J Cancer. 2001; 92: 899-905
- Childhood and recent eating patterns and risk of breast cancer.Cancer Detect Prev. 1986; 9: 47-58
- Oral contraceptive agents and breast cancer: a population-based case-control study.Med J Aust. 1988; 149: 520-526
- The pattern of risk factors for breast cancer in a southern France population: interest for a stratified analysis by age at diagnosis.Br J Cancer. 1991; 64: 919-925
- Breast cancer and breastfeeding: results from an Australian case-control study.Am J Epidemiol. 1989; 130: 229-236
- Oral contraceptive use and breast cancer in Indonesia.Contraception. 1993; 47: 241-249
- Risk factors for breast cancer among Filipino women.Philipp J Intern Med. 1994; 32: 231-236
- A case-control study of breast cancer in relation to oral contraceptive use in Slovenia.Neoplasma. 1988; 35: 109-121
- Reproductive and hormonal factors and breast cancer in a Northern Italian population.Int J Epidemiol. 1985; 14: 70-74
- A case-control study of breast cancer in Tianjin, China.Cancer Epidemiol Biomarkers Prev. 1992; 1: 435-439
- A case-control study of breast cancer in relation to the use of steroid contraceptive agents.Med J Aust. 1986; 144: 173-176
- Use of oral contraceptives and risk of breast cancer in young women.Breast Cancer Res Treat. 1998; 50: 175-184
- Oral contraceptives and breast cancer risk among younger women.J Natl Cancer Inst. 1995; 87: 827-835
- Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.Int J Cancer. 1998; 77: 219-223
- Oral contraceptive use and breast cancer risk in young women.Lancet. 1989; 1: 973-982
- Oral contraceptives and breast cancer: a French case-control study.Int J Epidemiol. 1991; 20: 32-38
- Oral contraceptives and breast cancer risk in Denmark.Eur J Cancer. 1992; 28A: 1176-1181
- A case-control study of risk factors for breast cancer in Brazil, 1978-1987.Int J Epidemiol. 1995; 24: 292-299
- A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study [in French].Contracept Fertil Sex (Paris). 1985; 13: 553-558
- A case-control study of breast cancer and hormonal contraception in Costa Rica.J Natl Cancer Inst. 1987; 79: 1247-1254
- Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore.Cancer Causes Control. 1992; 3: 313-322
- Oral contraceptives and the risk of breast cancer.N Engl J Med. 2002; 346: 2025-2032
- Adolescent reproductive events and subsequent breast cancer risk.Am J Public Health. 1999; 89: 1244-1247
- The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer: results of a case-control study.Cancer. 1988; 61: 173-180
- Breast cancer in Australian women under the age of 40.Cancer Causes Control. 1998; 9: 189-198
- Early oral contraceptive use and breast cancer: results of another case-control study.Br J Cancer. 1987; 56: 653-660
- Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway.Lancet. 1986; 2: 650-654
- Oral contraceptives and breast cancer among African-American women and white women.J Natl Med Assoc. 2001; 93: 329-334
- Recent oral contraceptive use and risk of breast cancer (United States).Cancer Causes Control. 1996; 7: 525-532
- Breast cancer and combined oral contraceptives: results from a multinational study.Br J Cancer. 1990; 61: 110-119
- Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.J Natl Cancer Inst. 1989; 81: 1000-1004
- Oral contraceptive use and breast cancer risk among African-American women.Cancer Causes Control. 1995; 6: 321-331
- Oral contraceptives and risk of breast cancer.Int J Cancer. 1990; 46: 366-373
- Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54.Int J Cancer. 1995; 62: 414-420
- Oral contraceptives and risk of breast cancer in women aged 20-54 years.Lancet. 1994; 344: 844-851
- A case-control study of the risk of breast cancer in relation to oral contraceptive use.Am J Epidemiol. 1992; 136: 1437-1444
- Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives [published correction appears in Am J Epidemiol. 2000;151:1134].Am J Epidemiol. 2000; 151: 396-403
- Oral contraceptive and breast cancer: a case-control study [in Portuguese].Rev Saude Publica. 2001; 35: 32-38
- Oral contraceptive use and breast cancer risk in areas with different incidence: a case-control study among young women.Ann N Y Acad Sci. 1996; 784: 564-569
- Breast cancer and oral contraceptive use in Asian-American women.Am J Epidemiol. 1999; 150: 561-567
- Breast cancer risk and oral contraceptive use: results from a large case-control study.Epidemiology. 1991; 2: 353-358
- Age-specific differences in the relationship between oral contraceptive use and breast cancer.Cancer. 1993; 71: 1506-1517
- Breast cancer among young U.S. women in relation to oral contraceptive use.J Natl Cancer Inst. 1994; 86: 505-514
- Risk factors for breast cancer in Chinese women in Shanghai.Cancer Res. 1988; 48: 1949-1953
- Case-control study of oral contraceptive use and risk of breast cancer.Am J Epidemiol. 1996; 143: 25-37
- Long-term oral contraceptive use and the risk of breast cancer.JAMA. 1983; 249: 1591-1595
- Oral-contraceptive use and the risk of breast cancer.N Engl J Med. 1986; 315: 405-411
- Oral contraceptives and premenopausal breast cancer in nulliparous women.Contraception. 1988; 38: 287-299
- Age-specific patterns of association between breast cancer and risk factors in black women, ages 20 to 39 and 40 to 54.Ann Epidemiol. 1994; 4: 205-213
- Breast cancer before age 45 and oral contraceptive use: new findings.Am J Epidemiol. 1989; 129: 269-280
- Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of use.Int J Epidemiol. 1989; 18: 527-532
- Meta-analysis in clinical trials.Control Clin Trials. 1986; 7: 177-188
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.Lancet. 1996; 347: 1713-1727
- Hormonal content and potency of oral contraceptives and breast cancer risk among young women.Br J Cancer. 2003; 88: 50-57
- The association of replacement estrogens with breast cancer.Int J Cancer. 1986; 37: 49-53
- Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.J Natl Cancer Inst. 1977; 59: 799-811
- Infiltrating duct carcinoma of the mammary gland of a rhesus monkey after administration of an oral contraceptive: a preliminary report.J Natl Cancer Inst. 1972; 48: 551-556
- FDA studies of estrogen, progestogens, and estrogen/progestogen combinations in the dog and monkey.J Toxicol Environ Health. 1977; 3: 179-193
- Oral contraceptives and breast cancer: laboratory evidence.IARC Sci Publ. 1985; : 33-35
- Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice.Cancer Lett. 1986; 33: 215-223
- 17beta-oestradiol and Enovid mammary tumorigenesis in C3H/HeJ female mice: counteraction by concurrent 2-bromo-alpha-ergocryptine.Br J Cancer. 1977; 35: 322-328
- Effect of long-term treatment with norethynodrel on A-J and C3H-HeJ mice.Endocrinology. 1969; 84: 661-668
- Oral contraceptive use influences resting breast proliferation.Hum Pathol. 1989; 20: 1139-1144
- Increased cell division as a cause of human cancer.Cancer Res. 1990; 50: 7415-7421
- Too many rodent carcinogens: mitogenesis increases mutagenesis.Science. 1990; 249: 970-971
- Cell proliferation in carcinogenesis.Science. 1990; 249: 1007-1011
- Postfertilization effects of oral contraceptives and their relationship to informed consent.Arch Fam Med. 2000; 9: 126-133
- Inhibin and relaxin concentrations in early singleton, multiple, and failing pregnancy: relationship to gonadotropin and steroid profiles.Fertil Steril. 1993; 59: 130-137
- Enhanced ovarian steroid secretion before implantation in early human pregnancy.J Clin Endocrinol Metab. 1993; 76: 1470-1476
- Another look at the pill and breast cancer.Lancet. 1985; 2: 985-987
- Oral contraceptives: the good news.JAMA. 1983; 249: 1624-1625
- Early oral contraceptive use and premenopausal breast cancer: a review of studies performed in southern Sweden.Cancer Detect Prev. 1991; 15: 265-271
- Oral contraceptives in relation to breast cancer.Epidemiol Rev. 1993; 15: 80-97
- Breast cancer in mothers prescribed diethylstilbestrol in pregnancy: further follow-up.JAMA. 1993; 269: 2096-2100
- Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.Cancer. 1991; 67: 1285-1290
- Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.J Natl Cancer Inst. 1991; 83: 1483-1487
- Survival in breast cancer and age at start of oral contraceptive usage.Anticancer Res. 1991; 11: 2043-2046
- Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.Cancer Epidemiol Biomarkers Prev. 1999; 8: 413-419
- Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.Am J Obstet Gynecol. 1998; 179: 577-582
- Oral contraceptive compliance and its role in the effectiveness of the method.in: Cramer JA Spilker B Patient Compliance In Medical Practice and Clinical Trials. Raven Press, New York1991: 195-207
- Risk of contraceptive discontinuation among adolescents.J Adolesc Health Care. 1989; 10: 527-533
- Comparison of recalled and validated oral contraceptive histories.Am J Epidemiol. 1993; 138: 697-703
- Risk factors for breast cancer with applications to selection for the prevalence screen.J Epidemiol Community Health. 1987; 41: 101-106
- Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study.BMJ. 1999; 318: 96-100
- Family history, age, and risk of fatal breast cancer.Am J Epidemiol. 1993; 138: 675-681
- Breast cancer and specific types of oral contraceptives: a large Norwegian cohort study.Int J Cancer. 2003; 105: 844-850
- Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.JAMA. 2000; 284: 1791-1798
- A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States).Cancer Causes Control. 1997; 8: 65-72
- Exogenous estrogen and breast cancer after bilateral oophorectomy.Cancer. 1984; 54: 139-144
- Breast cancer and the pill: a further report from the Royal College of General Practitioners' oral contraception study.Br J Cancer. 1988; 58: 675-680
- Use of oral contraceptives and breast cancer risk: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study.Cancer Epidemiol Biomarkers Prev. 2002; 11: 1375-1381
- Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years [published correction appears in CMAJ. 1993;148:718].CMAJ. 1992; 147: 1459-1476
- Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists.Cancer. 1989; 64: 591-597
- Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study.Cancer Causes Control. 1995; 6: 416-424
- Oral contraceptives and risk of breast cancer: a historical prospective case-control study.Acta Obstet Gynecol Scand. 1996; 75: 157-161
- A prospective cohort study of oral contraceptives and breast cancer.J Natl Cancer Inst. 1981; 67: 1011-1015
- Oral contraceptive use at a young age and the risk of breast cancer: an Icelandic, population-based cohort study of the effect of birth year.Br J Cancer. 1997; 75: 139-143
- Long-term oral contraceptive use increases breast cancer risk in women over 55 years of age: the DOM cohort.Int J Cancer. 2000; 87: 591-594
- Oral contraceptives and breast cancer: latest findings in a large cohort study.Br J Cancer. 1989; 59: 613-617
- Progestational potency of oral contraceptives.Obstet Gynecol. 1976; 47: 106-112
- Progestins and breast cancer: an epidemiologic review.Fertil Steril. 1992; 57: 473-491
- Depot medroxyprogesterone acetate and breast cancer: a pooled analysis of the World Health Organization and New Zealand studies.JAMA. 1995; 273: 799-804
- Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.JAMA. 2004; 291: 1701-1712
- Introduction of the pill and its impact.Contraception. 1999; 59: 11S-16S
Article Info
Footnotes
This work was supported in part by grant K07-CA80668 from the National Institutes of Health (F.M.).
Identification
Copyright
© 2006 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Oral Contraceptive Use and Breast Cancer Risk: Current StatusMayo Clinic ProceedingsVol. 81Issue 10
- PreviewOne might have thought that the issue of whether oral contraceptives (OCs) are associated with breast cancer risk would have been settled by now, given that these agents were introduced in the early 1960s and more than 60 case-control and 10 cohort studies, several meta-analyses,1–4 a very large pooled analysis,5 and a major monograph6 have addressed this issue. On the basis of the accumulated data, the International Agency for Research on Cancer (IARC) classified oral estrogen-progestogen contraceptives as carcinogenic to humans (group 1 carcinogen) in 2005, which is a higher classification than the 1999 IARC evaluation.
- Full-Text
- Preview
